Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 19, 2008Journal of Clinical OncologyOpen Access

Zoledronic Acid Prevents Bone Loss in Premenopausal Women Undergoing Adjuvant Chemotherapy for Early-Stage Breast Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

DHDawn L. HershmanRutgers, The State University of New JerseyDMDonald J. McMahonHospital for Special SurgeryKCKatherine D. CrewUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hershman et al. (2008) studied this question.

synapsesocial.com/papers/6ab736a8f05009e2a0fb8857https://doi.org/10.1200/jco.2008.16.4707
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.1997 · 266 citations
  2. 2A high incidence of vertebral fracture in women with breast cancer1999 · 257 citations
  3. 3Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer Treatment2005 · 956 citations
  4. 4Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study1996 · 1,000 citations